Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Persson

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
JAMA Network Open|October 1, 2020
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With OutcomesChristian Dworeck, Björn Redfors, Oskar Angerås, et al.
Journal of the American Heart Association|January 11, 2018
Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST-Segment-Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty RegistryOskar Angerås, Inger Haraldsson, Björn Redfors, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|June 12, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudyTania Sharma, Akiko Maehara, Michael Maeng, et al.
Circulation. Cardiovascular Interventions|September 25, 2024
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II SubstudyLars Kjøller-Hansen, Akiko Maehara, Henning Kelbæk, et al.
Journal of the American College of Cardiology|October 18, 2020
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueGregg W Stone, Akiko Maehara, Ziad A Ali, et al.
American Heart Journal|June 20, 2017
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trialOle Fröbert, Matthias Götberg, Oskar Angerås, et al.
The American Journal of Cardiology|March 24, 2015
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary interventionFabrizio D'Ascenzo, Salma Taha, Claudio Moretti, et al.
Atherosclerosis|January 15, 2015
Plasma IL-5 concentration and subclinical carotid atherosclerosisAngela Silveira, Olga McLeod, Rona J Strawbridge, et al.
Circulation|June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II SubstudyPernille G Thrane, Michael Maeng, Akiko Maehara, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 20, 2022
Health status and risk profiles for brain aging of rural-dwelling older adults: Data from the interdisciplinary baseline assessments in MIND-ChinaYongxiang Wang, Xiaolei Han, Xianda Zhang, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
JAMA Network Open|October 1, 2020
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With OutcomesChristian Dworeck, Björn Redfors, Oskar Angerås, et al.
Journal of the American Heart Association|January 11, 2018
Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST-Segment-Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty RegistryOskar Angerås, Inger Haraldsson, Björn Redfors, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|June 12, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudyTania Sharma, Akiko Maehara, Michael Maeng, et al.
Circulation. Cardiovascular Interventions|September 25, 2024
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II SubstudyLars Kjøller-Hansen, Akiko Maehara, Henning Kelbæk, et al.
Journal of the American College of Cardiology|October 18, 2020
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueGregg W Stone, Akiko Maehara, Ziad A Ali, et al.
American Heart Journal|June 20, 2017
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trialOle Fröbert, Matthias Götberg, Oskar Angerås, et al.
The American Journal of Cardiology|March 24, 2015
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary interventionFabrizio D'Ascenzo, Salma Taha, Claudio Moretti, et al.
Atherosclerosis|January 15, 2015
Plasma IL-5 concentration and subclinical carotid atherosclerosisAngela Silveira, Olga McLeod, Rona J Strawbridge, et al.
Circulation|June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II SubstudyPernille G Thrane, Michael Maeng, Akiko Maehara, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 20, 2022
Health status and risk profiles for brain aging of rural-dwelling older adults: Data from the interdisciplinary baseline assessments in MIND-ChinaYongxiang Wang, Xiaolei Han, Xianda Zhang, et al.
Pageof 22